Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model

Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination

(2022) Vijaykrishna Dhanasekaran et al.   Nature Communications

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

(2021) Nikolaos C. Kyriakidis et al.   npj Vaccines

Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy

(2021) Ying Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Mechanism behind Influenza Virus Cytokine Storm

(2021) Yinuo Gu et al.   Viruses-Basel

Advances in Development and Application of Influenza Vaccines

(2021) Jidang Chen et al.   Frontiers in Immunology

The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination

(2021) Madhusudan Rajendran et al.   Vaccines

Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review

(2021) Amit Bansal et al.   Frontiers in Immunology

Abdominal and Pelvic Organ Failure Induced by Intraperitoneal Influenza A Virus Infection in Mice

(2020) Avishekh Gautam et al.   Frontiers in Microbiology

The disease burden of influenza beyond respiratory illness

(2020) Alejandro E. Macias et al.   VACCINE

CD83 expression regulates antibody production in response to influenza A virus infection

(2020) Madhav Akauliya et al.   Virology Journal

Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus

(2020) Janika Wolff et al.   Vaccines

Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus

(2019) Avishekh Gautam et al.   Frontiers in Immunology

Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines

(2019) Pui Wang et al.   mBio

The emerging influenza virus threat: status and new prospects for its therapy and control

(2018) Binod Kumar et al.   ARCHIVES OF VIROLOGY

Towards a universal influenza vaccine: different approaches for one goal

(2018) Giuseppe A. Sautto et al.   Virology Journal

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

(2018) Stephanie Pepin et al.   VACCINE

Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial

(2017) Punnee Pitisuttithum et al.   LANCET INFECTIOUS DISEASES

Is It Possible to Develop a “Universal” Influenza Virus Vaccine?

(2017) Sarah F. Andrews et al.   Cold Spring Harbor Perspectives in Biology

Long-Term Immunogenicity of an Inactivated Split-Virion 2009 Pandemic Influenza A H1N1 Virus Vaccine with or without Aluminum Adjuvant in Mice

(2015) Wenting Xu et al.   Clinical and Vaccine Immunology

Live attenuated vaccines: Historical successes and current challenges

(2015) Philip D. Minor   VIROLOGY

Are the anatomical sites for vaccine administration selected judiciously?

(2014) Basant Malik et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice

(2012) Jianzhong Shi et al.   ANTIVIRAL RESEARCH

Live Attenuated S. Typhimurium Vaccine with Improved Safety in Immuno-Compromised Mice

(2012) Balamurugan Periaswamy et al.   PLoS One

Immunization with a Hemagglutinin-Derived Synthetic Peptide Formulated with a CpG-DNA-Liposome Complex Induced Protection against Lethal Influenza Virus Infection in Mice

(2012) Jae Won Rhee et al.   PLoS One

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

(2012) G.-M. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evidence based route of administration of vaccines

(2011) Ian F. Cook   Human vaccines & immunotherapeutics

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

(2011) Jens Wrammert et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells

(2011) M. L. B. Hillaire et al.   JOURNAL OF GENERAL VIROLOGY

Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets

(2011) R. Bodewes et al.   JOURNAL OF VIROLOGY

Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus

(2011) Katie Harris et al.   Virology Journal

Seasonal FluMist Vaccination Induces Cross-Reactive T Cell Immunity against H1N1 (2009) Influenza and Secondary Bacterial Infections

(2010) K. Sun et al.   JOURNAL OF IMMUNOLOGY

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

(2009) Jianhua Sui et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Intranasal Flu Vaccine Protective against Seasonal and H5N1 Avian Influenza Infections

(2009) Mohammed Alsharifi et al.   PLoS One

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

(2009) D. C. Ekiert et al.   SCIENCE

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

(2008) Mark Throsby et al.   PLoS One